⌘K

Home/Filings/4/0001213900-21-021026

4//SEC Filing

Feldmann Marc 4

Accession 0001213900-21-021026

CIK 0001690080other

View on SEC.gov Company Profile

Filed

Apr 8, 8:00 PM ET

Accepted

Apr 9, 4:16 PM ET

Size

4.8 KB

Accession

0001213900-21-021026

Insider Transaction Report

Form 4

Period: 2021-04-07

180 Life Sciences Corp.ATNF

Director10% Owner

Transactions

Award
Common Stock
2021-04-07$6.14/sh+20,910$128,387→ 2,617,758 total

Footnotes (1)

[F1]Issued in consideration for accrued compensation due for services rendered as Co-Executive Chairman of the Issuer. Granted under the registrant's 2020 Omnibus Incentive Plan. Exempt from Section 16(b) pursuant to Rule 16b-3.

Documents

1 file

4
ownership.xmlPrimary

Issuer

180 Life Sciences Corp.

CIK 0001690080

Entity typeother

Related Parties

1

filerCIK 0001832327

Filing Metadata

Form type: 4
Filed: Apr 8, 8:00 PM ET
Accepted: Apr 9, 4:16 PM ET
Size: 4.8 KB

View on SEC.gov